The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Angiotensin II-Induced Production of Mitochondrial Reactive Oxygen Species: Potential Mechanisms and Relevance for Cardiovascular Disease
Open accessAbstract
SIGNIFICANCE: The role of reactive oxygen species (ROS) in angiotensin II (AngII) induced endothelial dysfunction, cardiovascular and renal remodeling, inflammation, and fibrosis has been well documented. The molecular mechanisms of AngII pathophysiological activity involve the stimulation of NADPH oxidases, which produce superoxide and hydrogen peroxide. AngII also increases the production of mitochondrial ROS, while the inhibition of AngII improves mitochondrial function; however, the specific molecular mechanisms of the stimulation of mitochondrial ROS is not clear. RECENT ADVANCES: Interestingly, the overexpression of mitochondrial thioredoxin 2 or mitochondrial superoxide dismutase attenuates AngII-induced hypertension, which demonstrates the importance of mitochondrial ROS in AngII-mediated cardiovascular diseases. CRITICAL ISSUES: Although mitochondrial ROS plays an important role in normal physiological cell signaling, AngII, high glucose, high fat, or hypoxia may cause the overproduction of mitochondrial ROS, leading to the feed-forward redox stimulation of NADPH oxidases. This vicious cycle may contribute to the development of pathological conditions and facilitate organ damage in hypertension, atherosclerosis, and diabetes. FUTURE DIRECTIONS: The development of antioxidant strategies specifically targeting mitochondria could be therapeutically beneficial in these disease conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ATR1 also increases reactive oxygen species from mitochondria in monocytes/macrophages leading to DNA damage and apoptosis of T cells resulting in endothelial injury and lymphopenia.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [60]
Experimental — accuracy not yet measuredIn the citing paper
“However, the rescue of the dysfunction was not complete, possibly implicating ROS sources other than NOX2 (33).”
From Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension (2016) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ushio‐Fukai, M., Griendling, K. K., Becker, P. L., Hilenski, L. L., Halleran, S., & Alexander, R. W. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.4.489 · Cited by 283
RetractedChobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
NOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress
Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1574 · Cited by 1,520
Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., & Griendling, K. K. (2001) · Circulation Research · doi:10.1161/hh0901.090299 · Cited by 839
Mitochondrial Dysfunction in Atherosclerosis
Madamanchi, N. R., & Runge, M. S. (2007) · Circulation Research · doi:10.1161/01.res.0000258450.44413.96 · Cited by 802
Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases
Martyn, K. D., Frederick, L. M., von Loehneysen, K., Dinauer, M. C., & Knaus, U. G. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.023 · Cited by 783
Cross talk between mitochondria and NADPH oxidases
Dikalov, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.033 · Cited by 783
Self-citationNADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart
Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M. D., & Sadoshima, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002178107 · Cited by 772
Therapeutic Targeting of Mitochondrial Superoxide in Hypertension
Dikalova, A., Bikineyeva, A. T., Budzyn, K., Nazarewicz, R. R., McCann, L. A., Lewis, W., Harrison, D. G., & Dikalov, S. (2010) · Circulation Research · doi:10.1161/circresaha.109.214601 · Cited by 745
Self-citationAngiotensin II Stimulation of NAD(P)H Oxidase Activity
Seshiah, P., Weber, D. S., Ročić, P., Valppu, L., Taniyama, Y., & Griendling, K. K. (2002) · Circulation Research · doi:10.1161/01.res.0000033523.08033.16 · Cited by 711
Doughan, A. K., Harrison, D. G., & Dikalov, S. I. (2008) · Circulation Research · doi:10.1161/circresaha.107.162800 · Cited by 710
Self-citationMinireview: Overview of the Renin-Angiotensin System—An Endocrine and Paracrine System
Lavoie, J. L., & Sigmund, C. D. (2003) · Endocrinology · doi:10.1210/en.2003-0150 · Cited by 576
Distinct Subcellular Localizations of Nox1 and Nox4 in Vascular Smooth Muscle Cells
Hilenski, L. L., Clempus, R. E., Quinn, M. T., Lambeth, J. D., & Griendling, K. K. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000112024.13727.2c · Cited by 573
Wang, Y., & Wang, Q. J. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2126 · Cited by 572
The E-loop Is Involved in Hydrogen Peroxide Formation by the NADPH Oxidase Nox4
Takac, I., Schröder, K., Zhang, L., Lardy, B., Anilkumar, N. P., Lambeth, J. D., Shah, A. M., Morel, F., & Brandes, R. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.192138 · Cited by 539
Ago, T., Kuroda, J., Pain, J., Fu, C., Li, H., & Sadoshima, J. (2010) · Circulation Research · doi:10.1161/circresaha.109.213116 · Cited by 506
Disruption of the Ang II type 1 receptor promotes longevity in mice
Benigni, A., Corna, D., Zoja, C., Sonzogni, A., Latini, R., Salio, M., Conti, S., Rottoli, D., Longaretti, L., Cassis, P., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36703 · Cited by 486
Subcellular localization of Nox4 and regulation in diabetes
Block, K. L., Gorin, Y. C., & Abboud, H. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906805106 · Cited by 484
Zhang, M., Brewer, A. C., Schröder, K., Santos, C. X. C., Grieve, D., Wang, M., Anilkumar, N. P., Yu, B., Dong, X., Walker, S. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009700107 · Cited by 452
Poldip2, a Novel Regulator of Nox4 and Cytoskeletal Integrity in Vascular Smooth Muscle Cells
Lyle, A. N., Deshpande, N. N., Taniyama, Y., Seidel-Rogol, B., Pounkova, L., Du, P., Papaharalambus, C., Lassègue, B., & Griendling, K. K. (2009) · Circulation Research · doi:10.1161/circresaha.109.193722 · Cited by 428
Superoxide Mediates the Actions of Angiotensin II in the Central Nervous System
Zimmerman, M. C., Lazartigues, E. D., Lang, J., Sinnayah, P., Ahmad, I. M., Spitz, D. R., & Davisson, R. L. (2002) · Circulation Research · doi:10.1161/01.res.0000043501.47934.fa · Cited by 395
Dikalov, S., Dikalova, A., Bikineyeva, A. T., Schmidt, H. H. H. W., Harrison, D. G., & Griendling, K. K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.08.013 · Cited by 391
Self-citationMitochondrial Targeted Antioxidant Peptide Ameliorates Hypertensive Cardiomyopathy
Dai, D., Chen, T., Szeto, H. H., Nieves‐Cintrón, M., Kutyavin, V. I., Santana, L. F., & Rabinovitch, P. S. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.12.044 · Cited by 367
Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling
Gao, L., & Mann, G. E. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp031 · Cited by 333
Salt Intake, Oxidative Stress, and Renal Expression of NADPH Oxidase and Superoxide Dismutase
Kitiyakara, C., Chabrashvili, T., Chen, Y., Blau, J., Karber, A., Aslam, S., Welch, W. J., & Wilcox, C. S. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000092145.90389.65 · Cited by 307
Guzik, T. J., Chen, W., Gongora, M. C., Guzik, B., Lob, H. E., Mangalat, D., Hoch, N., Dikalov, S., Rudzinski, P., Kapelak, B., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.063 · Cited by 281
Self-citationMitochondria in the diabetic heart
Bugger, H., & Abel, E. D. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq239 · Cited by 265
Kimura, S., Zhang, G.-X., Nishiyama, A., Shokoji, T., Yao, L., Fan, Y.-Y., Rahman, M., Suzuki, T., Maeta, H., & Abe, Y. (2005) · Hypertension · doi:10.1161/01.hyp.0000163462.98381.7f · Cited by 264
Involvement of Nox2 NADPH Oxidase in Adverse Cardiac Remodeling After Myocardial Infarction
Looi, Y. H., Grieve, D., Siva, A., Walker, S. J., Anilkumar, N. P., Cave, A. C., Marber, M. S., Monaghan, M. J., & Shah, A. M. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.101980 · Cited by 256
Uncoupled Cardiac Nitric Oxide Synthase Mediates Diastolic Dysfunction
Silberman, G. A., Fan, T. M., Liu, H., Jiao, Z., Xiao, H., Lovelock, J. D., Boulden, B. M., Widder, J. D., Fredd, S., Bernstein, K. E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.883777 · Cited by 254
Self-citationNox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy
Zhao, Y., McLaughlin, D., Robinson, E., Harvey, A., Hookham, M. B., Shah, A. M., McDermott, B. J., & Grieve, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2664 · Cited by 245
Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS
Rodríguez‐Pallares, J., Rey, P., Parga, J. A., Muñoz, A., Guerra, M. J., & Labandeira-García, J. L. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.03.003 · Cited by 213
Stanley, B. A., Sivakumaran, V., Shi, S., McDonald, I., Lloyd, D., Watson, W. H., Aon, M. A., & Paolocci, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.284612 · Cited by 203
NAD(P)H Oxidase-Derived Reactive Oxygen Species as Mediators of Angiotensin II Signaling
Hanna, I. R., Taniyama, Y., Szöcs, K., Ročić, P., & Griendling, K. K. (2002) · Antioxidants and Redox Signaling · doi:10.1089/152308602762197443 · Cited by 195
Anilkumar, N. P., Weber, R., Zhang, M., Brewer, A. C., & Shah, A. M. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.164277 · Cited by 195
Hsieh, T., Zhang, S., Filep, J. G., Tang, S., Ingelfinger, J. R., & Chan, J. S. D. (2002) · Endocrinology · doi:10.1210/endo.143.8.8931 · Cited by 190
Enalapril and losartan attenuate mitochondrial dysfunction in aged rats
de Cavanagh, E. M. V., Piotrkowski, B., Basso, N., Stella, I., Inserra, F., Ferder, L., & Fraga, C. G. (2003) · The FASEB Journal · doi:10.1096/fj.02-0063fje · Cited by 186
Cai, H. “., Li, Z., Dikalov, S., Holland, S. M., Hwang, J., Jo, H., Dudley, S. C., & Harrison, D. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208884200 · Cited by 182
Self-citationIncreased Nox2 expression in human cardiomyocytes after acute myocardial infarction
Krijnen, P. A. J., Meischl, C., Hack, C. E., Meijer, C. J. L. M., Visser, C. A., Roos, D., & Niessen, H. W. M. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.3.194 · Cited by 177
Lob, H. E., Marvar, P. J., Guzik, T. J., Sharma, S., McCann, L. A., Weyand, C. M., Gordon, F. J., & Harrison, D. G. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.142646 · Cited by 177
Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo
Brewer, A. C., Murray, T. V., Arno, M. J., Zhang, M., Anilkumar, N. P., Mann, G. E., & Shah, A. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.022 · Cited by 170
Hingtgen, S., Tian, X., Yang, J., Dunlay, S. M., Peek, A. S., Wu, Y., Sharma, R. V., Engelhardt, J. F., & Davisson, R. L. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00029.2005 · Cited by 153
Nishino, Y., Miura, T., Miki, T., Sakamoto, J., Nakamura, Y., Ikeda, Y., Kobayashi, H., & Shimamoto, K. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.10.022 · Cited by 144
Superoxide Mediates Angiotensin II–Induced Influx of Extracellular Calcium in Neural Cells
Zimmerman, M. C., Sharma, R. V., & Davisson, R. L. (2005) · Hypertension · doi:10.1161/01.hyp.0000153463.22621.5e · Cited by 144
Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?
de Cavanagh, E. M. V., Inserra, F., & Ferder, L. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq285 · Cited by 139
Widder, J. D., Fraccarollo, D., Galuppo, P., Hansen, J. M., Jones, D. P., Ertl, G., & Bauersachs, J. K. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.127928 · Cited by 136
Quast, U., Stephan, D., Bieger, S., & Ruß, U. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s156 · Cited by 125
de Cavanagh, E. M. V., Toblli, J. E., Ferder, L., Piotrkowski, B., Stella, I., & Inserra, F. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00615.2005 · Cited by 120
Rodríguez‐Iturbe, B., Sepassi, L., Quiroz, Y., Ni, Z., & Vaziri, N. D. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00513.2006 · Cited by 115
Sun, L., Xiao, L., Nie, J., Liu, F.-Y., Ling, G.-H., Zhu, X.-J., Tang, W.-B., Chen, W.-C., Xia, Y.-C., Zhan, M., et al. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00414.2010 · Cited by 114
Redox regulation of the mitochondrial KATP channel in cardioprotection
Queliconi, B. B., Wojtovich, A. P., Nadtochiy, S. M., Kowaltowski, A. J., & Brookes, P. S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.11.005 · Cited by 101
Pivotal role of NOX‐2‐containing NADPH oxidase in early ischemic preconditioning
Bell, R. M., Cave, A. C., Johar, S., Hearse, D. J., Shah, A. M., & Shattock, M. J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2774fje · Cited by 95
Lou, M., Blume, A., Zhao, Y., Gohlke, P., Deuschl, G., Herdegen, T., & Čulman, J. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200405000-00008 · Cited by 90
Infanger, D. W., Cao, X., Butler, S. D., Burmeister, M. A., Zhou, Y., Stupinski, J. A., Sharma, R. V., & Davisson, R. L. (2010) · Circulation Research · doi:10.1161/circresaha.109.213025 · Cited by 89
Whaley‐Connell, A. T., Habibi, J., Nistala, R., Cooper, S. A., Karuparthi, P. R., Hayden, M. R., Rehmer, N., DeMarco, V. G., Andresen, B. T., Wei, Y., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.102467 · Cited by 89
Mitochondrial Dysfunction as an Initiating Event in Atherogenesis: A Plausible Hypothesis
Puddu, P., Puddu, G. M., Galletti, L., Cravero, E., & Muscari, A. (2005) · Cardiology · doi:10.1159/000083440 · Cited by 86
Rossi, R., Cioni, E., Nuzzo, A., Origliani, G., & Modena, M. G. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.702 · Cited by 74
Dai, D., & Rabinovitch, P. S. (2011) · Autophagy · doi:10.4161/auto.7.8.15813 · Cited by 73
Role of Vascular Extracellular Superoxide Dismutase in Hypertension
Lob, H. E., Vinh, A., Li, L., Blinder, Y., Offermanns, S., & Harrison, D. G. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.172718 · Cited by 60
Renal mitochondrial impairment is attenuated by AT 1 blockade in experimental Type I diabetes
de Cavanagh, E. M. V., Ferder, L., Toblli, J. E., Piotrkowski, B., Stella, I., Fraga, C. G., & Inserra, F. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00926.2007 · Cited by 54
Angiotensin II and angiotensin-1-7 redox signaling in the central nervous system
Zimmerman, M. C. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.01.001 · Cited by 48
Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney disease
Nistala, R., Wei, Y., Sowers, J. R., & Whaley‐Connell, A. T. (2009) · Translational research · doi:10.1016/j.trsl.2008.12.008 · Cited by 46
Angiotensin II blockade improves mitochondrial function in spontaneously hypertensive rats.
de Cavanagh, E. M. V., Toblli, J. E., Ferder, L., Piotrkowski, B., Stella, I., Fraga, C. G., & Inserra, F. (2005) · PubMed · Cited by 39
Valsartan improves mitochondrial function in hearts submitted to acute ischemia
Monteiro, P. F., Duarte, A. I., Gonçalves, L. M. M., & Providência, L. A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.06.013 · Cited by 24
Pomerantz, B. J., Robinson, T. N., Heimbach, J. K., Calkins, C. M., Miller, S. A., Banerjee, A. M., & Harken, A. H. (2000) · Surgery · doi:10.1067/msy.2000.107423 · Cited by 19
Research works printed but not linked: 3
- Bell RM, 2005, FASEB J Off Publ Fed Am Soc Exp Biol, 19, 2037
- De Cavanagh EM, 2005, Cell Mol Biol, 51, 573
- 10.1210/en.143.8.2975 · DOI
Cited by
Sorted by citations
Obesity and cancer risk: Emerging biological mechanisms and perspectives
Avgerinos, K. I., Spyrou, N., Mantzoros, C. S., & Dalamaga, M. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.001 · Cited by 1,567
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R. G., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,135
Mitochondrial dysfunction and oxidative stress in heart disease
Peoples, J. N., Saraf, A., Ghazal, N., Pham, T. T., & Kwong, J. Q. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0355-7 · Cited by 950
Obesity, Inflammation, and Cancer
Deng, T., Lyon, C. J., Bergin, S. M., Caligiuri, M. A., & Hsueh, W. A. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044359 · Cited by 831
Goette, A., Kalman, J. M., Aguinaga, L., Akar, J. G., Cabrera, J. Á., Chen, S. A., Chugh, S. S., Corradi, D., d’Ávila, A., Dobrev, D., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.05.028 · Cited by 791
Metadata
- Authors
- Dikalov, S. I., & Nazarewicz, R. R.
- Affiliations
- Vanderbilt University Medical Center (US)
- ORCID
- Dikalov, Sergey I.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2013-10
- Volume
- 19
- Issue
- 10
- Pages
- 1085-1094
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- PMC
- PMC3771548
- OpenAlex
- W2085076776
- Cited by
- 356
- References
- 68
- Citations by year
- 2026: 25 · 2025: 29 · 2024: 22 · 2023: 38 · 2022: 32 · 2021: 49 · 2020: 34 · 2019: 22 · 2018: 19 · 2017: 21 · 2016: 26 · 2015: 20 · 2014: 9 · 2013: 8
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antioxidants and Redox Signaling (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL094469, HL094469)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- angiotensin II, mitochondrial reactive oxygen species, NADPH oxidase, superoxide, hydrogen peroxide, thioredoxin 2, mitochondrial superoxide dismutase, hypertension, atherosclerosis, diabetes mellitus, endothelial dysfunction, renal remodeling, mitochondrial dysfunction, antioxidant therapy
- MeSH terms
- Angiotensin II, Animals, Cardiovascular Diseases, Humans, Hydrogen Peroxide, Mitochondria, Superoxide Dismutase, Signal Transduction, Reactive Oxygen Species, Oxidative Stress, NADPH Oxidases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
